AURA Aura Biosciences Inc

Price (delayed)

$6.82

Market cap

$705.1M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.74

Enterprise value

$636.53M

?
Relative Growth: Rel. Growth: 7
Relative Strength: Rel. Strength: 59
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 4

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet ...

Highlights
Aura Biosciences's EPS has increased by 8% YoY
AURA's debt is down by 8% YoY and by 2.2% from the previous quarter
AURA's quick ratio is down by 35% YoY and by 12% from the previous quarter
AURA's equity is down by 22% since the previous quarter and by 16% year-on-year

Key stats

What are the main financial stats of AURA

AURA stock price

How has the Aura Biosciences stock price performed over time
Intraday
-0.87%
1 week
-9.07%
1 month
-18.32%
1 year
11.07%
YTD
25.14%
QTD
1.94%

Financial performance

How have Aura Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$118.62M
Net income
-$112.39M
Gross margin
N/A
Net margin
N/A
The company's net income fell by 19% YoY and by 6% QoQ
AURA's operating income is down by 15% year-on-year and by 5% since the previous quarter

Price vs fundamentals

How does AURA's price correlate with its fundamentals

Growth

What is Aura Biosciences's growth rate over time

Valuation

What is Aura Biosciences stock price valuation
P/E
N/A
P/B
4.08
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Aura Biosciences's EPS has increased by 8% YoY
AURA's price to book (P/B) is 53% more than its 5-year quarterly average of 2.7 and 53% more than its last 4 quarters average of 2.7
AURA's equity is down by 22% since the previous quarter and by 16% year-on-year

Efficiency

How efficient is Aura Biosciences business performance
AURA's return on invested capital has dropped by 95% year-on-year and by 24% since the previous quarter
Aura Biosciences's return on equity has decreased by 33% YoY and by 10% QoQ
The return on assets has declined by 29% year-on-year and by 8% since the previous quarter

Dividends

What is AURA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AURA.

Financial health

How did Aura Biosciences financials performed over time
AURA's current ratio is down by 36% year-on-year and by 13% since the previous quarter
AURA's quick ratio is down by 35% YoY and by 12% from the previous quarter
AURA's debt is 84% less than its equity
The debt to equity is up by 23% since the previous quarter and by 14% year-on-year
AURA's equity is down by 22% since the previous quarter and by 16% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.